# US 6,730,703 B2 · Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,703 B2
- Document ID: US6730703B2
- Status: Granted
- Kind: B2
- Application number: 10/182,847
- Filed: 2002-08-02
- Published: 2003-03-27
- Granted: 2004-05-04
- Earliest claimed: 2000-02-02
- Assignees: Warner-Lambert Company
- Inventors: Reynold Homan
- Web page: https://patentgrep.com/patent/US6730703B2

## CPC

- A61K 31/255: of sulfoxy acids or sulfur analogues thereof
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/08: Antiseborrheics
- A61P 17/10: Anti-acne agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a method of treating sebaceous gland disorders comprising administering to a patient in need of said treatment an effective amount of a compound named [(2,4,6-triisopropyl-phenyl)-acetyl]-sulfamic acid 2,6-diiso-propyl-phenyl ester or a pharmaceutically acceptable salt thereof. Particularly, methods of treating sebaceous gland disorders are provided wherein said disorders are selected from seborrhea, acnes, perioral dermatitis, rosacea, and corticosteroid-induced acneiform lesions. The present invention provides methods of treating acnes such as, for example, chloracne, ciliaris acne, cystic acne, keratosa acne, vulgaris acne, senile acne, and medicinal acne.

## Claims

### Claim 1

A method of treating sebaceous gland disorders comprising administering to a patient in need of said treatment an effective amount of a compound named [(2,4,6-triisopropyl-phenyl)-acetyl]-sulfamic acid 2,6-diisopropyl-phenyl ester or a pharmaceutically acceptable salt thereof wherein the sebaceous gland disorder is selected from the group consisting of seborrhea and rosacea.

### Claim 2 (depends on 1)

A method according to claim 1 wherein said disorder is seborrhea.

### Claim 3 (depends on 1)

A method according to claim 1 wherein said disorder is rosacea.
